Clinical Trials Directory

Trials / Completed

CompletedNCT04859556

Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

As technology advances, vitrectomy cutters are smaller and cut rates have become faster. In this prospective study, the vitrectomy efficiency and safety between 5,000 cuts per minute with 10,000 cuts per minute are compared

Detailed description

Purpose: This study aims to compare the performance of the Alcon 25+® UltraVit® 5000 cpm vitrectomy probe versus the 25+® Ultravit 10,000 cpm® beveled tip, dual drive vitrectomy probe. The safety profile and efficiency were compared. Method: Prospective, randomised study. Consecutive patients from January 2019 to August 2019 requiring vitrectomy for retinal detachment, epiretinal membrane, vitreous haemorrhage, and macula hole were randomized into either the 10K or 5K vitrectomy group. Both groups underwent vitrectomy using the proportional vacuum mode with the cut rate set at the fastest rate. Patients with previous vitrectomy, other ocular diseases (glaucoma, corneal disease, or significant corneal opacities), or trauma were excluded from the study. The primary endpoint was vitrectomy time, while secondary endpoints included posterior vitreous detachment time, intraoperative complications, and number of instruments used. The preoperative, postoperative 1 month and 3 month best corrected visual acuity (BCVA), and complications were recorded.

Conditions

Interventions

TypeNameDescription
DEVICEAlcon 25Gauge, 10,000 cuts per minute Ultravit cuttera proprietary Vitrector from Alcon for the use on the Constellation system
DEVICEAlcon 25Gauge, 5,000 cuts per minute Ultravit cuttera proprietary Vitrector from Alcon for the use on the Constellation system

Timeline

Start date
2018-05-01
Primary completion
2019-01-01
Completion
2020-06-01
First posted
2021-04-26
Last updated
2021-04-26

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04859556. Inclusion in this directory is not an endorsement.